Kyverna Therapeutics
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Kyverna Therapeutics
RECRUITINGNCT07403188
A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
The purpose of this long-term follow-up (LTFU) study is to collect delayed adverse events (AEs) and understand the persistence of KYV-101 (autologous CAR T cell product;...
Sponsor: Kyverna TherapeuticsEnrolling: 701 location
Refractory Lupus NephritisMyasthaenia GravisStiff Person Syndrome+4
RECRUITINGPhase 2 / Phase 3NCT06193889
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
A Study of the Anti-CD 19 Chimeric Antigen Receptor T Cell Therapy for Patients with Myasthenia Gravis
Sponsor: Kyverna TherapeuticsEnrolling: 6615 locations
Myasthenia GravisGeneralized Myasthenia Gravis